These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32026179)

  • 1. Early changes of vascular lesions and responses to combined photodynamic therapy in patients with polypoidal choroidal vasculopathy.
    Asano-Shimizu K; Asano S; Murata H; Azuma K; Nomura Y; Inoue T; Ogawa A; Asaoka R; Obata R
    Int Ophthalmol; 2020 Jun; 40(6):1335-1345. PubMed ID: 32026179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P; Anantharaman G; Gopalakrishnan M; Goyal A
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports.
    Iesato Y; Tanaka M; Murata M; Kitahara J; Hirano T; Kurenuma T; Yoshida N; Murata T
    BMC Ophthalmol; 2018 Nov; 18(1):284. PubMed ID: 30390650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept-Source Optical Coherence Tomography Angiography.
    Kim K; Yang J; Feuer W; Gregori G; Kim ES; Rosenfeld PJ; Yu SY
    Am J Ophthalmol; 2020 Sep; 217():240-251. PubMed ID: 32445699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Polypoidal Choroidal Vasculopathy With Optical Coherence Tomography Angiography.
    Wang M; Zhou Y; Gao SS; Liu W; Huang Y; Huang D; Jia Y
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT526-32. PubMed ID: 27472276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Optical Coherence Tomography Angiography.
    Tomiyasu T; Nozaki M; Yoshida M; Ogura Y
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT324-30. PubMed ID: 27409489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood flow characteristics of polypoidal choroidal vasculopathy and the choroidal remodelling process after photodynamic therapy.
    Chen Y; Yang Z; Xia F; Ning H; Hua R
    Lasers Surg Med; 2018 Jul; 50(5):427-432. PubMed ID: 29399845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.
    Bo Q; Yan Q; Shen M; Song M; Sun M; Yu Y; Rosenfeld PJ; Wang F; Sun X
    JAMA Ophthalmol; 2019 Jun; 137(6):642-650. PubMed ID: 30998817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report.
    Rouvas A; Gouliopoulos NS; Moschos MM; Theodossiadis P
    BMC Ophthalmol; 2018 Oct; 18(1):267. PubMed ID: 30309335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management strategy of polypoidal choroidal vasculopathy.
    Ho CPS; Lai TYY
    Indian J Ophthalmol; 2018 Dec; 66(12):1727-1735. PubMed ID: 30451173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REDUCED VASCULAR DENSITY IN THE CHOROID AFTER TREATMENT WITH PHOTODYNAMIC THERAPY COMBINED WITH AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Mukai R; Matsumoto H; Miyakubo T; Akiyama H
    Retina; 2021 Jan; 41(1):156-161. PubMed ID: 32251239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects.
    Rishi P; Rishi E; Sharma M; Maitray A; Bhende M; Gopal L; Sharma T; Ratra D; Sen P; Bhende P; Rao C; Susvar P
    Indian J Ophthalmol; 2017 Aug; 65(8):712-718. PubMed ID: 28820157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial.
    Lim TH; Lai TYY; Takahashi K; Wong TY; Chen LJ; Ruamviboonsuk P; Tan CS; Lee WK; Cheung CMG; Ngah NF; Patalauskaite R; Margaron P; Koh A;
    JAMA Ophthalmol; 2020 Sep; 138(9):935-942. PubMed ID: 32672800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral-Domain Optical Coherence Tomography Angiography for the Diagnosis and Evaluation of Polypoidal Choroidal Vasculopathy.
    de Carlo TE; Kokame GT; Shantha JG; Lai JC; Wee R
    Ophthalmologica; 2018; 239(2-3):103-109. PubMed ID: 29227980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of branching neovascular networks in polypoidal choroidal vasculopathy by optical coherence tomography angiography after photodynamic therapy and anti-vascular endothelial growth factor combination therapy.
    Wang WY; Yang CH; Chen TC; Hsieh YT; Ho TC; Yang CM; Liu FY; Lai TT
    Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2249-2260. PubMed ID: 35133487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Coherence Tomography Angiography for Assessment of the 3-Dimensional Structures of Polypoidal Choroidal Vasculopathy.
    Chi YT; Yang CH; Cheng CK
    JAMA Ophthalmol; 2017 Dec; 135(12):1310-1316. PubMed ID: 29049501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Multispectral Imaging.
    Zhang J; Yan Y; Yu Z; Liu L
    Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):e249-e255. PubMed ID: 30566710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy.
    Takayama K; Ito Y; Kaneko H; Kataoka K; Sugita T; Maruko R; Hattori K; Ra E; Haga F; Terasaki H
    Eye (Lond); 2017 Jan; 31(1):45-52. PubMed ID: 27813526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 choroidal neovascularisation in polypoidal choroidal vasculopathy: a retrospective case series.
    Liang S; Shi X; Rosenfeld PJ; Li X
    Br J Ophthalmol; 2018 Nov; 102(11):1570-1574. PubMed ID: 29436399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy.
    Wong IY; Shi X; Gangwani R; Zhao P; Iu LP; Li Q; Ng A; Li X
    BMC Ophthalmol; 2015 Jun; 15():66. PubMed ID: 26122636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.